Therefore, it is predicted that both umbelliferone and scopoletin can act on TKs to regulate biological processes, including cell adhesion, cell-cell junction formation, and cell polarization, which are all critical during RA progression (Weyand and Goronzy, 2021). This evidence concerns the gene CDC42 and rheumatoid arthritis.